These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20008887)

  • 41. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.
    Quaas AM; Missmer SA; Ginsburg ES
    Fertil Steril; 2010 Feb; 93(2):605-8. PubMed ID: 19324340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assisted reproductive technology surveillance--United States, 2000.
    Wright VC; Schieve LA; Reynolds MA; Jeng G
    MMWR Surveill Summ; 2003 Aug; 52(9):1-16. PubMed ID: 14532867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
    Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
    Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Transvaginal ultrasonography in the treatment of infertility by the method of extracorporeal fertilization].
    Solomatina EV; Zdanovskiĭ VM; Kechiian KN; Anshina MB
    Akush Ginekol (Mosk); 1990 Jul; (7):48-51. PubMed ID: 2240450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should IVF be used as first-line treatment or as a last resort? A debate presented at the 2013 Canadian Fertility and Andrology Society meeting.
    Huang LN; Tan J; Hitkari J; Dahan MH
    Reprod Biomed Online; 2015 Feb; 30(2):128-36. PubMed ID: 25498596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Agreement between self-reported use of in vitro fertilization or ovulation induction, and medical insurance claims in Australian women aged 28-36 years.
    Herbert D; Lucke J; Dobson A
    Hum Reprod; 2012 Sep; 27(9):2823-8. PubMed ID: 22740497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laparotomy ovum pick-up and ultrasonic transvaginal ovum retrieval in an IVF program.
    Zhang LZ; Chen GA; Zhao WX; Wang ZM; Li MZ; Liu P; Wang XY; Zhao YF
    Chin Med J (Engl); 1990 Oct; 103(10):851-5. PubMed ID: 2125259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
    Ng EH; Chan CC; Tang OS; Ho PC
    Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection.
    Narkiewicz K; Burnier M; Kjeldsen SE; Oparil S
    Blood Press; 2021 Oct; 30(5):267-268. PubMed ID: 34586009
    [No Abstract]   [Full Text] [Related]  

  • 52. Telemedicine in assisted reproduction.
    Valdera Simbrón CJ; Hernández Rodríguez C
    Reprod Biomed Online; 2021 Jan; 42(1):269-272. PubMed ID: 33293221
    [No Abstract]   [Full Text] [Related]  

  • 53. Is home-based monitoring of ovulation to time frozen embryo transfer a cost-effective alternative for hospital-based monitoring of ovulation? Study protocol of the multicentre, non-inferiority Antarctica-2 randomised controlled trial.
    Zaat TR; de Bruin JP; Goddijn M; van Baal M; Benneheij EB; Brandes EM; Broekmans F; Cantineau AEP; Cohlen B; van Disseldorp J; Gielen SCJP; Groenewoud ER; van Heusden A; Kaaijk EM; Koks C; de Koning CH; Klijn NF; Lambalk CB; van der Linden PJQ; Manger P; van Oppenraaij RHF; Pieterse Q; Smeenk J; Visser J; van Wely M; Mol F
    Hum Reprod Open; 2021; 2021(4):hoab035. PubMed ID: 35692982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Home- or hospital-based monitoring to time frozen embryo transfer in the natural cycle? Patient-reported outcomes and experiences from the Antarctica-2 randomised controlled trial.
    Zaat TR; de Bruin JP; Goddijn M; Visser J; Kaaijk EM; Lambalk CB; Groenewoud ER; van Wely M; Mol F
    Hum Reprod; 2020 Apr; 35(4):866-875. PubMed ID: 32318722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between sonographic follow-up of follicular growth, serum and salivary estradiol in women undergoing controlled ovarian stimulation (IVF/ICSI).
    Rottiers AS; Dalewyn L; Somers S; Alper MM; Sakkas D; Gerris J
    Facts Views Vis Obgyn; 2018 Dec; 10(4):173-179. PubMed ID: 31367289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI.
    Dielen C; Fiers T; Somers S; Deschepper E; Gerris J
    Facts Views Vis Obgyn; 2017 Jun; 9(2):85-91. PubMed ID: 29209484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome of one hundred consecutive ICSI attempts using patient operated home sonography for monitoring follicular growth.
    Gerris J; Vandekerckhove F; De Sutter P
    Facts Views Vis Obgyn; 2016 Sep; 8(3):141-146. PubMed ID: 28003868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pilot study comparing the DuoFertility(®) monitor with ultrasound in infertile women.
    Rollason JC; Outtrim JG; Mathur RS
    Int J Womens Health; 2014; 6():657-62. PubMed ID: 25075200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Male subfertility: communication, care, coping. An explorative study.
    Ninclaus V; Van Mossevelde S; Stuyver I; Grypdonck M; De Sutter P; Gerris J
    Facts Views Vis Obgyn; 2010; 2(4):253-65. PubMed ID: 25009713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-operated endovaginal telemonitoring (SOET): a step towards more patient-centred ART?
    Gerris J; De Sutter P
    Hum Reprod; 2010 Mar; 25(3):562-8. PubMed ID: 20008887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.